ArticleFrontiers in medicine2025
Red blood cell distribution width-to-albumin ratio and its association with age-related macular degeneration: a population-based cross-sectional study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Role of Systemic Inflammation in Age-Related Macular Degeneration Subtypes: Exploring Novel Biomarkers.Diagnostics (Basel, Switzerland) · 2026Article
- The Relationship of the Red Cell Distribution Width-to-Albumin Ratio and Other Inflammatory Markers With Cataracts: An Analysis of the NHANES Population.Translational vision science & technology · 2026Article
- Red blood cell distribution width/albumin ratio (RAR): A novel predictor of retinal vein occlusion in the Turkish population (STROBE).Medicine · 2026Article
- High-fat diet, triglyceride glucose index, and gastrointestinal cancer: integrative insights from human and animal studies.Frontiers in nutrition · 2026Article
- Association between red blood cell distribution width to albumin ratio (RAR) and cataract risk: A cross-sectional study from NHANES 1999-2008.Advances in ophthalmology practice and researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Age-related macular degeneration (AMD) is a leading cause of central vision impairment in middle-aged and older individuals. There is substantial evidence that AMD is associated with inflammation. The study aimed to investigate the association between the inflammatory marker, red blood cell distribution width/albumin ratio (RAR), and AMD. Methods: Our study included 5,370 participants aged 40 years and older, using NHANES data from 2005 to 2008. Multivariable logistic regression analysis was conducted to examine the relationship between RAR and AMD in the study. Smooth curves and the piecewise linear regression model were used to determine whether the correlation was linear or non-linear. Additionally, subgroup analysis and interaction testing were performed. Results: We found a positive linear correlation between RAR and AMD, even after adjusting for covariates. Each unit increase in RAR corresponded to a 30% increase in the odds of AMD prevalence (OR = 1.3; 95% CI, 1.0-1.6). The odds of AMD prevalence were 1.7 times greater in the highest quintile (Q5) group than in the lowest quintile (Q1) group (OR = 1.7; 95% CI, 1.2-2.5). Higher RAR values, compared to lower values, were significantly associated with increased odds of AMD prevalence ( Conclusion: This study found that there is a positive linear correlation between RAR and the odds of AMD prevalence in United States adults. Further research is necessary to clarify the specific physiological mechanisms underlying the relationship between RAR and AMD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.